Statistical contributions to phase II trials in cancer: interpretation, analysis and design.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004341:Drug Evaluation / Q000379:methods*; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D011897:Random Allocation; D012107:Research Design; D013223:Statistics as Topic
D000970:Antineoplastic Agents; D008727:Methotrexate